Lista de obras -

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria

artículo científico publicado en 2013

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

artículo científico publicado en 2016

Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology

scientific article published on 09 August 2019

Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer

Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement

artículo científico publicado en 2016

Automated objective determination of percentage of malignant nuclei for mutation testing

artículo científico publicado en 2014

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

artículo científico publicado en 2017

Basic Overview of Current Immunotherapy Approaches in Cancer

artículo científico publicado en 2016

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

scientific article published on 06 April 2020

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

artículo científico publicado en 2020

Cation permeation through connexin 43 hemichannels is cooperative, competitive and saturable with parameters depending on the permeant species ⬇️

artículo científico publicado el 12 de mayo de 2011

Cell membrane permeabilization via connexin hemichannels in living and dying cells

artículo científico publicado en 2010

Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer.

artículo científico publicado en 2018

Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis

scientific article published on 18 July 2019

Connexin 43 hemichannels mediate the Ca2+ influx induced by extracellular alkalinization.

artículo científico publicado en 2010

Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses

artículo científico publicado en 2008

Currently used methods for identification and characterization of hemichannels

artículo científico publicado en 2008

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

artículo científico publicado en 2016

Dysfunctions of the diffusional membrane pathways mediated by hemichannels in inherited and acquired human diseases

artículo científico publicado en 2009

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma

artículo científico publicado en 2016

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.

artículo científico publicado en 2015

Effects of Radiation on the Tumor Microenvironment

scientific article published on 01 April 2020

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

scientific article published on 11 May 2020

Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?

artículo científico publicado en 2016

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

scientific article published on 03 May 2019

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

scholarly article by Daniel Carvajal-Hausdorf et al published 8 March 2019 in Journal for Immunotherapy of Cancer

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

artículo científico publicado en 2018

HER2 gene amplification and overexpression in advanced gastric cancer

artículo científico publicado en 2013

High SOX2 levels predict better outcome in non-small cell lung carcinomas

artículo científico publicado en 2013

Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy

artículo científico publicado en 2019

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations

scientific article published on 26 September 2018

Immune checkpoint inhibitors in thoracic malignancies: Review of the existing evidence by an IASLC expert panel and recommendations

scientific article published on 13 March 2020

Immunodivergence in Metastatic Colorectal Cancer

artículo científico publicado en 2018

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

scientific article published on 01 March 2019

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

artículo científico publicado en 2017

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas

artículo científico publicado en 2014

Interleukin-8 in cancer pathogenesis, treatment and follow-up

artículo científico publicado en 2017

KRAS gene mutation in colorectal cancer

artículo científico publicado en 2013

Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas

artículo científico publicado en 2013

Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer

artículo científico publicado en 2015

Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration

artículo científico publicado en 2009

Modulation of gap junction channels and hemichannels by growth factors.

artículo científico

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand (PD-L)-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

artículo científico publicado en 2018

Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry

scientific article published on 22 February 2019

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

artículo científico publicado en 2019

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice.

artículo científico publicado en 2015

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

artículo científico publicado en 2017

Objective measurement and clinical significance of TILs in non-small cell lung cancer

artículo científico publicado en 2015

Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance

artículo científico publicado en 2017

Oncolytic virus immunotherapy: future prospects for oncology

scholarly article by Junaid Raja et al published 4 December 2018 in Journal for Immunotherapy of Cancer

Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential

artículo científico publicado en 2007

Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer

artículo científico publicado en 2014

PD-1/PD-L1 blockers in NSCLC brain metastases: challenging paradigms and clinical practice

scientific article published on 30 April 2020

PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer

artículo científico publicado en 2014

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer

artículo científico publicado en 2014

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.

artículo científico publicado en 2018

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

scientific article published on 03 April 2020

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

scientific article published on 27 November 2019

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)

scientific article published on 29 November 2019

Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion.

artículo científico publicado en 2007

Possible role of hemichannels in cancer

artículo científico publicado en 2014

Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images.

artículo científico publicado en 2017

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research

artículo científico publicado en 2016

Primary cerebral lymphomatoid granulomatosis in a HIV-positive patient. Case report

artículo científico publicado el 11 de julio de 2011

Programmed death ligand-1 expression in non-small cell lung cancer

artículo científico publicado en 2013

Quality of DNA from archival pathological samples of gallbladder cancer

artículo científico publicado en 2013

Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer

scientific article published on 09 October 2019

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.

artículo científico publicado en 2016

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer

artículo científico publicado en 2016

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic

artículo científico publicado en 2014

Regulation of Intercellular Calcium Signaling Through Calcium Interactions with Connexin-Based Channels ⬇️

artículo científico publicado el 1 de enero de 2012

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).

artículo científico publicado en 2013

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer

artículo científico publicado en 2018

Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non-small cell lung cancer

artículo científico publicado en 2017

Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats

artículo científico publicado en 2015

Strategies to design clinical studies to identify predictive biomarkers in cancer research.

artículo científico publicado en 2016

Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma

scientific article published on 09 November 2019

Unvalidated antibodies and misleading results

artículo científico publicado en 2014

[BRAF gene mutation in wild-type KRAS patients with colorectal cancers].

artículo científico publicado en 2014

p16ink4a Expression in Benign and Malignant Melanocytic Conjunctival Lesions ⬇️

artículo científico publicado el 26 de enero de 2012

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology

Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer

Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement

Automated objective determination of percentage of malignant nuclei for mutation testing

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Basic Overview of Current Immunotherapy Approaches in Cancer

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

Cation permeation through connexin 43 hemichannels is cooperative, competitive and saturable with parameters depending on the permeant species ⬇️

Cell membrane permeabilization via connexin hemichannels in living and dying cells

Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer.

Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis

Connexin 43 hemichannels mediate the Ca2+ influx induced by extracellular alkalinization.

Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses

Currently used methods for identification and characterization of hemichannels

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Dysfunctions of the diffusional membrane pathways mediated by hemichannels in inherited and acquired human diseases

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.

Effects of Radiation on the Tumor Microenvironment

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

HER2 gene amplification and overexpression in advanced gastric cancer

High SOX2 levels predict better outcome in non-small cell lung carcinomas

Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations

Immune checkpoint inhibitors in thoracic malignancies: Review of the existing evidence by an IASLC expert panel and recommendations

Immunodivergence in Metastatic Colorectal Cancer

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas

Interleukin-8 in cancer pathogenesis, treatment and follow-up

KRAS gene mutation in colorectal cancer

Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas

Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer

Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration

Modulation of gap junction channels and hemichannels by growth factors.

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand (PD-L)-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice.

Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

Objective measurement and clinical significance of TILs in non-small cell lung cancer

Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance

Oncolytic virus immunotherapy: future prospects for oncology

Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential

Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer

PD-1/PD-L1 blockers in NSCLC brain metastases: challenging paradigms and clinical practice

PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)

Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion.

Possible role of hemichannels in cancer

Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images.

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research

Primary cerebral lymphomatoid granulomatosis in a HIV-positive patient. Case report

Programmed death ligand-1 expression in non-small cell lung cancer

Quality of DNA from archival pathological samples of gallbladder cancer

Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic

Regulation of Intercellular Calcium Signaling Through Calcium Interactions with Connexin-Based Channels ⬇️

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer

Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non-small cell lung cancer

Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats

Strategies to design clinical studies to identify predictive biomarkers in cancer research.